Antisense and RNAi Therapeutics Market Global Trends, Market Share, Industry Size, Growth, Opportunities and Market Forecast – 2021 to 2027

The global market for Antisense and RNAi Therapeutics estimated at US$ 1.2 Billion in the year 2020, is projected to reach a revised size of US$ 1.9 Billion by 2027, growing at a CAGR of 6% over the period 2021-2027.

Antisense and RNAi therapeutics are a new class of drugs that work by silencing parts of RNA through the use of short interfering RNAs (siRNAs) or microRNAs (miRNAs) that cause disease or induce degradation of target mRNAs. Reduce the translation of undesirable proteins using RNases.

 

Market Segments

By Technology
• RNA Interference
• Antisense RNA

By Application  
• Oncology
• Cardiovascular Diseases (CVDs)
• Respiratory Disorders
• Renal Diseases
• Neurodegenerative Disorders
• Genetic Disorders
• Infectious Diseases
• Other

By Route of Administration
• Pulmonary Delivery
• Intravenous Injections
• Intra-dermal Injections
• Intraperitoneal Injections
• Topical Delivery
• Other

Key Players

Some of the industry players in this market include Alnylam, Mirus Bio, Marina Biotech, Benitec Biopharma, RXi pharmaceuticals, Qiagen, Genzyme, and Moderna.

Scope of the Report

The research study analyzes the global Antisense and RNAi Therapeutics industry from 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions, considering multiple aspects some of which are listed below as:

Recent Developments

o Market Overview and growth analysis
o Import and Export Overview
o Volume Analysis
o Current Market Trends and Future Outlook
o Market Opportunistic and Attractive Investment Segment

Geographic Coverage

o North America Market Size and/or Volume
o Latin America Market Size and/or Volume
o Europe Market Size and/or Volume
o Asia-Pacific Market Size and/or Volume
o Rest of the world Market Size and/or Volume

Key Questions Answered by Antisense and RNAi Therapeutics Market Report

1. What was the Antisense and RNAi Therapeutics Market size in 2019 and 2020; what are the estimated growth trends and market forecast (2021-2027).

2. What will be the CAGR of the Antisense and RNAi Therapeutics Market during the forecast period (2021-2027)?
3. Which segments (product type/applications/end-user) were most attractive for investments in 2021? How these segments are expected to grow during the forecast period (2021-2027).
4. Which manufacturer/vendor/players in the Antisense and RNAi Therapeutics Market was the market leader in 2020?
5. Overview on the existing product portfolio, products in the pipeline, and strategic initiatives taken by key vendors in the market.